Skip to main content
. 2025 Jun 10;312(3):857–870. doi: 10.1007/s00404-025-08059-7

Table 3.

Comparison of TXNIP levels and metabolic parameters across PCOS groups with different BMI and control

Parameter Ctrl. (n = 102) OB-PCOS (n = 21) OW-PCOS (n = 38) P-value
Age (years) 24.62 ± 4.67 25.52 ± 4.09 24.84 ± 4.71 0.739
AMH (ng/mL) 8.13 ± 3.17 7.28 ± 3.23 7.44 ± 3.41 0.369
HCY (µmol/L) 11.83 ± 3.75 12.04 ± 3.86 11.31 ± 3.59 0.702
HOMA-IR 1.60 ± 1.14 4.33 ± 3.04 2.75 ± 1.73  < 0.001
Fins (mU/L) 7.32 ± 4.68 18.46 ± 11.53 12.13 ± 6.91  < 0.001
FBG (mmol/L) 4.84 ± 0.39 5.16 ± 0.69 4.95 ± 0.54 0.017
CRP (mg/L) 1.86 ± 2.62 3.61 ± 2.97 2.52 ± 2.67 0.020
TG (mmol/L) 0.98 ± 0.55 1.85 ± 1.04 1.43 ± 0.76  < 0.001
HDL (mmol/L) 1.60 ± 0.36 1.13 ± 0.23 1.30 ± 0.26  < 0.001
LDL (mmol/L) 2.58 ± 0.72 2.91 ± 0.70 2.76 ± 0.78 0.103
TC (mmol/L) 4.74 ± 0.84 4.92 ± 0.84 4.70 ± 0.94 0.628
TXNIP (ng/mL) 0.30 ± 0.07 0.38 ± 0.11 0.33 ± 0.11  < 0.001

Note: P < 0.05 indicates statistical significance. Data are expressed as mean ± standard deviation

Abbreviations: AMH Anti-Müllerian hormone, HCY Homocysteine, HOMA-IR Homeostatic Model Assessment Index, Fins Fasting insulin, FBG Fasting blood glucose, CRP C-reactive protein, TG Triglycerides, HDL High-density lipoprotein, LDL Low-density lipoprotein, TC Total cholesterol, TXNIP Thioredoxin-interacting protein, OB-PCOS Obese PCOS group, OW-PCOS Overweight PCOS group, CTRL Control group